when did semaglutide get approved Semaglutide: The Drug of Today and a Steppingstone to Tomorrow Following FDA nod, Novo Nordisk

In the 20-week study, participants receiving exenatide once-monthly achieved similar improvements in blood glucose control (average A1c reductions between 1.3% and 1.5%) as those receiving Bydureon (average A1c reduction of 1.5%)

However, human clinical trials involving thousands of patients over multiple years have found zero confirmed cases of MTC attributable to GLP-1 use, and the FDA has not issued any safety warnings based on human data

Slowed gastric emptying, weight loss, and favorable results on lipid parameters have all been associated with GLP-1RAs use [40]

Full Ingredient List / Technical Specifications Vitamin C (1%): A potent antioxidant that targets melanin production

I think I have a sensitive gut and the booze harmed the small intestine

to improve blood sugar levels in adults with type 2 diabetes mellitus who have severe kidney problems (if their eGFR is less than 30 mL/min/1.73 m2)